Kidney cancer trials in Czechia

In Czechia 7 Also abroad 485

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Brno-Stred, Hradec Králové, Olomouc, Ostrava, Prague, Prague 2
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Brno, Brno-Stred, České Budějovice, Hradec Králové, Olomouc, Prague
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Where
Brno-Stred, Hradec Králové, Prague
Age
18 years and over
People
474 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Brno-Stred, Olomouc, Prague
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 3Taking people
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Where
Brno-Stred, Novy Hradec Kralove, Olomouc, Plzen 23, Prague
Age
18 years and over
People
1,373 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-503317-29-00 · EU 2023-503317-29-00
Phase 3Taking people
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Where
Brno-Stred, České Budějovice, Hradec Králové, Olomouc, Ostrava, Prague, Prague 2
Age
18 years and over
People
904 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00
Phase 3Taking people
CARE1 Pragmatic Clinical Trial
Where
Brno, Hradec Králové, Olomouc, Prague
Age
18 years and over
People
1,250 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT06364631